Jupiter life line hospital Limited has announced its participation in an upcoming investor conference, providing stakeholders with an opportunity to engage directly with company officials. The healthcare company filed the requisite disclosure with stock exchanges on February 4, 2026, in compliance with regulatory requirements.

Meeting Details and Schedule

The investor engagement is scheduled as part of the Nuvama Conference, with specific arrangements outlined for interested participants.

Regulatory Compliance and Information Sharing

The company has emphasized its commitment to regulatory compliance and transparent communication practices. Jupiter Life Line Hospitals Limited confirmed that all discussions during the investor interactions will be based exclusively on publicly available documents. The company explicitly stated that no unpublished price sensitive information (UPSI) will be discussed during these meetings, ensuring adherence to securities regulations.

Accessibility and Documentation

To maintain transparency, the company announced that details of the investor meeting will be made available on its official website at www.jupiterhospital.com . This ensures broader accessibility for stakeholders who may wish to review the information shared during the conference.

Operational Flexibility

The company has noted that the scheduled meeting details may be subject to changes due to operational exigencies on the part of either the host organization or the company itself. This provision allows for necessary adjustments while maintaining the commitment to investor engagement.

The disclosure was signed by Suma Upparatti, Company Secretary & Compliance Officer, demonstrating proper corporate governance protocols in the announcement of this investor relations activity.

Jupiter Life Line Hospital Limited has announced its earnings conference call to discuss the operational and financial performance for Q3 & 9M FY26. The call is scheduled for February 02, 2026 at 10:00 AM IST and will provide insights into the company's quarterly and nine-month performance.

Conference Call Details

The earnings call will be represented by Dr. Ankit Thakker, Joint Managing Director and CEO, along with the senior management team. The company has issued formal notification to both National Stock Exchange of India Limited and BSE Limited under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Access Information

Investors and analysts interested in participating in the earnings call are required to pre-register through the company's designated registration link. The company has provided multiple access numbers to accommodate participants from different regions.

Regulatory Compliance

The company has fulfilled its regulatory obligations by notifying the stock exchanges about the earnings call. The notification was signed by Suma Upparatti, Company Secretary & Compliance Officer, on January 23, 2026. The earnings call information will also be made available on the company's official website at www.jupiterhospital.com .

Coordination Support

Strategic Growth Advisors Pvt. Ltd. is coordinating the earnings call, with Mandar Chavan and Rahul Agarwal serving as the primary contacts. Participants can reach them at mandar.chavan@sgapl.net or rahul.agarwal@sgapl.net , or through phone numbers 9699382195 and 9821438864 respectively.